Medical International Supervision Measures are becoming stricter and stricter of domestic and foreign markets
Release time: 2012-02-07 & nbsp & nbsp & nbsp Source:
According to the introduction of the Chinese pharmaceutical and health care products，International supervision measures for pharmaceuticals are becoming stricter，The foreign trade environment is even more severe。To ensure public health and safety，In recent years，Governments of various countries continue to improve the quality standard system of pharmaceutical products，Raise market entry thresholds one after another，Increase the supervision and inspection of overseas manufacturers，Strengthen the monitoring and traceability of upstream products。
May 1, 2011，EU "Traditional Herbal Directive" forced implementation，I need to register in my Chinese medicine to continue to be sold; June，EU Drug Administration promulgated the new law，Requires from July 1, 2013，All western medicine preparations and their raw medicines that lose Europe must meet the same standards as the EU's good operation stake betting appStake Sports Bettingspecifications (GMP)，and require export companies to accept regular or irregular verifications, etc.。At the same time，European Medicine Quality Administration (EDQM) further strengthened the control of imported raw materials，extended the scope of supervision to the initial reaction; emerging countries have gradually improved the entry threshold for import pharmaceutical products，If Peru requires the import preparation to meet the GMP standard，Brazil has begun to adopt a record system for medical devices。Generally speaking，The preparation procedures faced by Chinese pharmaceutical companies are becoming more complicated，The production conditions and quality standards that need to be met are endless。
International Order Limited and Short -term Development，Corporate profits are becoming thinner。2011，Continuous downturn from global economy、Market demand growth is weak、RMB exchange rate trend is difficult to predict factors and other factors，Overseas buyers are more inclined to adopt short orders、Sanda order replacement of previous long -term orders，To reduce trade risks，Chinese pharmaceutical companies' new export orders are small -valued、Short -term development trend。In addition，Affected by natural disasters and domestic inflation，Raw materials、Logistics、Labor and other factors have risen sharply，My medical foreign trade enterprise is still in the state of micro -profit operation。According to the sampling survey of the Medical Protection Merchant Council，About 50%of the profit margin of pharmaceutical companies is below 5%，Among them, 20%of the corporate profit margin is only 1%。profitability continues to linger at low level，Coupled with the lack of effective encouragement policies My stake betting appstake betting appand capital support，Enterprise development in the international market、Transformation and upgrading and technical development ability are facing increasingly severe challenges。
Frequency of trade relief cases in China，advantageous products to grab beach overseas frustration。After the financial crisis，Global pharmaceutical market is weak，The growth of the traditional pharmaceutical market is weak，The trend of international trade protectionism is up，Chinese pharmaceutical products have quickly become the key goal of trade relief measures to China abroad。2011，My medical products have encountered more than 10 cases of foreign trade relief cases，Together in the total amount of cases in 2009 and 2010。The products involved are mainly concentrated in penicillin industrial salt、Amoxicin、Sugar Essence、Coenzyme Q10 and other advantageous raw materials and medical consumables，The general export amount of the case involved in the case is large、Investigation subjects to concentrated on long -term competitive products、The characteristics of focusing on domestic leading pharmaceutical companies，Trade relief means extended from guarantee measures and anti -dumping to anti -subsidy and 337 survey，Trade relief cases have expanded from traditional European and American markets to India、Mexico and other emerging markets。Developed countries and my main competitors are using trade relief measures as a means，Drag my medical company to grab the international market of the beach。
Foreign capital accelerates the layout in China，Multiple games in domestic and foreign markets are becoming more complicated。2011，Multinational pharmaceutical companies show the expansion of ambitions in China，Relying on strong economic stake betting appstrength and industry stake online sports bettinginfluence，Conform to the trend of integration of the Chinese pharmaceutical industry，Through joint venture、merger and reorganization method，Speed up the Chinese market。Following the fourth quarter of 2010, GlaxoSmithk invested $ 70 million to acquire Nanjing Merri Pharmaceutical Co., Ltd.、American pharmaceutical and medical service providers Cardinal Cardinal Group (Cardinal) spent $ 470 million to acquire China Yongyu Medicine，2011，multinational pharmaceutical giants further increase investment in China，Ensure into the field of production and distribution in heavy capital，Effectively consolidate market position。
Early year，American Biopharmaceutical Enterprise Sai Sheng Pharmaceutical Co., Ltd. (Scicklone) spent $ 104.8 million to acquire Chinese pharmaceutical distribution marketing company Novamed (NOVAMED)，The transaction is completed in the short term，rapidly enhanced the influence of Cai Sheng Pharmaceutical in the Chinese market; in June, the world's largest pharmaceutical merchant Pfizer and the well -known domestic characteristic raw and pharmaceutical company Hemong Pharmaceuticals jointly invested 295 million US dollars to set up a joint venture，Cooperation for domestic markets、Research and Development Patent Drugs，Play Haizheng Pharmaceuticals、The advantages of generic drug production and the effectively combined with Pfizer's sales and marketing channels at China Hospital; July，The world's largest pharmaceutical circulation and pharmaceutical and health product retail chain company British United Boxi Group, after participating in Guangzhou Pharmaceutical Group in 2007，Hand in hand again in China's fifth largest distribution giant Nanjing My stake betting appPharmaceutical Group，Increase stake online sports bettingthe internal reorganization of Nanjing Pharmaceutical Group with capital increase，The scope of its own medical distribution in China has expanded from Guangdong to the southeast coast，To further integrate into the Chinese market、Realizing localization growth lays a solid foundation; July，Xianyin Pharmaceutical Group signed a cooperation agreement with Merck，Establish a joint venture in China，Effective combination of selected brands with both parties with imitation drugs，Fully build a leading brand in China ’s cardiovascular disease drugs; in addition，Huahai Pharmaceutical、Haixiang Pharmaceutical and other listed companies and foreign -funded cooperation with foreign capital also further deepen。
May 1, 2011，EU "Traditional Herbal Directive" forced implementation，I need to register in my Chinese medicine to continue to be sold; June，EU Drug Administration promulgated the new law，Requires from July 1, 2013，All western medicine preparations and their raw medicines that lose Europe must meet the same standards as the EU's good operation stake betting appStake Sports Bettingspecifications (GMP)，and require export companies to accept regular or irregular verifications, etc.。At the same time，European Medicine Quality Administration (EDQM) further strengthened the control of imported raw materials，extended the scope of supervision to the initial reaction; emerging countries have gradually improved the entry threshold for import pharmaceutical products，If Peru requires the import preparation to meet the GMP standard，Brazil has begun to adopt a record system for medical devices。Generally speaking，The preparation procedures faced by Chinese pharmaceutical companies are becoming more complicated，The production conditions and quality standards that need to be met are endless。
International Order Limited and Short -term Development，Corporate profits are becoming thinner。2011，Continuous downturn from global economy、Market demand growth is weak、RMB exchange rate trend is difficult to predict factors and other factors，Overseas buyers are more inclined to adopt short orders、Sanda order replacement of previous long -term orders，To reduce trade risks，Chinese pharmaceutical companies' new export orders are small -valued、Short -term development trend。In addition，Affected by natural disasters and domestic inflation，Raw materials、Logistics、Labor and other factors have risen sharply，My medical foreign trade enterprise is still in the state of micro -profit operation。According to the sampling survey of the Medical Protection Merchant Council，About 50%of the profit margin of pharmaceutical companies is below 5%，Among them, 20%of the corporate profit margin is only 1%。profitability continues to linger at low level，Coupled with the lack of effective encouragement policies My stake betting appstake betting appand capital support，Enterprise development in the international market、Transformation and upgrading and technical development ability are facing increasingly severe challenges。
Frequency of trade relief cases in China，advantageous products to grab beach overseas frustration。After the financial crisis，Global pharmaceutical market is weak，The growth of the traditional pharmaceutical market is weak，The trend of international trade protectionism is up，Chinese pharmaceutical products have quickly become the key goal of trade relief measures to China abroad。2011，My medical products have encountered more than 10 cases of foreign trade relief cases，Together in the total amount of cases in 2009 and 2010。The products involved are mainly concentrated in penicillin industrial salt、Amoxicin、Sugar Essence、Coenzyme Q10 and other advantageous raw materials and medical consumables，The general export amount of the case involved in the case is large、Investigation subjects to concentrated on long -term competitive products、The characteristics of focusing on domestic leading pharmaceutical companies，Trade relief means extended from guarantee measures and anti -dumping to anti -subsidy and 337 survey，Trade relief cases have expanded from traditional European and American markets to India、Mexico and other emerging markets。Developed countries and my main competitors are using trade relief measures as a means，Drag my medical company to grab the international market of the beach。
Foreign capital accelerates the layout in China，Multiple games in domestic and foreign markets are becoming more complicated。2011，Multinational pharmaceutical companies show the expansion of ambitions in China，Relying on strong economic stake betting appstrength and industry stake online sports bettinginfluence，Conform to the trend of integration of the Chinese pharmaceutical industry，Through joint venture、merger and reorganization method，Speed up the Chinese market。Following the fourth quarter of 2010, GlaxoSmithk invested $ 70 million to acquire Nanjing Merri Pharmaceutical Co., Ltd.、American pharmaceutical and medical service providers Cardinal Cardinal Group (Cardinal) spent $ 470 million to acquire China Yongyu Medicine，2011，multinational pharmaceutical giants further increase investment in China，Ensure into the field of production and distribution in heavy capital，Effectively consolidate market position。
Early year，American Biopharmaceutical Enterprise Sai Sheng Pharmaceutical Co., Ltd. (Scicklone) spent $ 104.8 million to acquire Chinese pharmaceutical distribution marketing company Novamed (NOVAMED)，The transaction is completed in the short term，rapidly enhanced the influence of Cai Sheng Pharmaceutical in the Chinese market; in June, the world's largest pharmaceutical merchant Pfizer and the well -known domestic characteristic raw and pharmaceutical company Hemong Pharmaceuticals jointly invested 295 million US dollars to set up a joint venture，Cooperation for domestic markets、Research and Development Patent Drugs，Play Haizheng Pharmaceuticals、The advantages of generic drug production and the effectively combined with Pfizer's sales and marketing channels at China Hospital; July，The world's largest pharmaceutical circulation and pharmaceutical and health product retail chain company British United Boxi Group, after participating in Guangzhou Pharmaceutical Group in 2007，Hand in hand again in China's fifth largest distribution giant Nanjing My stake betting appPharmaceutical Group，Increase stake online sports bettingthe internal reorganization of Nanjing Pharmaceutical Group with capital increase，The scope of its own medical distribution in China has expanded from Guangdong to the southeast coast，To further integrate into the Chinese market、Realizing localization growth lays a solid foundation; July，Xianyin Pharmaceutical Group signed a cooperation agreement with Merck，Establish a joint venture in China，Effective combination of selected brands with both parties with imitation drugs，Fully build a leading brand in China ’s cardiovascular disease drugs; in addition，Huahai Pharmaceutical、Haixiang Pharmaceutical and other listed companies and foreign -funded cooperation with foreign capital also further deepen。
